Skip to main content
TipRanks
Go Ultimate75% OFF

Clover Biopharmaceuticals Ltd. (2197) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Clover Biopharmaceuticals Ltd. has a market cap or net worth of HKD 2.16B. The enterprise value is HKD 1.97B.

Market Cap
HKD 2.16B
Enterprise Value
HKD 1.97B

Share Statistics

Clover Biopharmaceuticals Ltd. has 1,298,789,900 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
1,298,789,900
Owned by Insiders
―
Owned by Institutions
0.47%

Financial Efficiency

Clover Biopharmaceuticals Ltd.’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 19.48%.

Return on Equity (ROE)
0.11
Return on Assets (ROA)
-0.44
Return on Invested Capital (ROIC)
19.48%
Return on Capital Employed (ROCE)
0.19
Revenue Per Employee
13.29K
Profits Per Employee
-777.37K
Employee Count
257
Asset Turnover
0.01
Inventory Turnover
2.76

Valuation Ratios

The current PE Ratio of Clover Biopharmaceuticals Ltd. is 2.15. Clover Biopharmaceuticals Ltd.’s PEG ratio is 0.00.

PE Ratio
2.15
PS Ratio
4347.22
PB Ratio
-2.24
Price to FCF
-7.07
Price to Operating Cash Flow
-6.89
PEG Ratio
0.00

Income Statement

In the last 12 months, Clover Biopharmaceuticals Ltd. had revenue of 3.41M and earned -199.78M in profits. Earnings per share was -0.16.

Revenue
3.41M
Gross Profit
-23.85M
Operating Income
-247.75M
Pretax Income
-199.78M
Net Income
-199.78M
EBITDA
-221.24M
Earnings Per Share (EPS)
-0.16

Cash Flow

In the last 12 months, operating cash flow was -260.44M and capital expenditures -614, giving a free cash flow of -260.44M billion.

Operating Cash Flow
-260.44M
Free Cash Flow
-260.44M
Free Cash Flow per Share
-0.21

Dividends & Yields

Clover Biopharmaceuticals Ltd. pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-14.19%
Earnings Yield
47.11%

Stock Price Statistics

Beta
1.73
52-Week Price Change
-38.56%
50-Day Moving Average
1.71
200-Day Moving Average
2.09
Relative Strength Index (RSI)
58.54
Average Volume (3m)
3.26M

Important Dates

Clover Biopharmaceuticals Ltd. upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).

Last Earnings Date
Aug 25, 2026
Next Earnings Date
Mar 30, 2027
Ex-Dividend Date
―

Financial Position

Clover Biopharmaceuticals Ltd. as a current ratio of 0.19, with Debt / Equity ratio of -0.59%

Current Ratio
0.19
Quick Ratio
0.19
Debt to Market Cap
0.00
Net Debt to EBITDA
1.18
Interest Coverage Ratio
-674.64

Taxes

In the past 12 months, Clover Biopharmaceuticals Ltd. has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Clover Biopharmaceuticals Ltd. EV to EBITDA ratio is -6.97, with an EV/FCF ratio of -6.71.

EV to Sales
4126.15
EV to EBITDA
-6.97
EV to Free Cash Flow
-6.71
EV to Operating Cash Flow
-6.71

Balance Sheet

Clover Biopharmaceuticals Ltd. has HKD 104.77M in cash and marketable securities with HKD 2.08M in debt, giving a net cash position of HKD 102.68M billion.

Cash & Marketable Securities
HKD 104.77M
Total Debt
HKD 2.08M
Net Cash
HKD 102.68M
Net Cash Per Share
HKD 0.08
Tangible Book Value Per Share
-HKD 0.65

Margins

Gross margin is -9099.11%, with operating margin of -64902.56%, and net profit margin of 199197.33%.

Gross Margin
-9099.11%
Operating Margin
-64902.56%
Pretax Margin
198352.64%
Net Profit Margin
199197.33%
EBITDA Margin
-59215.47%
EBIT Margin
-64902.56%

Analyst Forecast

The average price target for Clover Biopharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
-99.15%
EPS Growth Forecast
―

Scores

Smart Score
5
AI Score
45